illustration 0 4 1 2 n 35 per arm per stage
play

Illustration: =0.4%, =1.2% n =35 per-arm per-stage Do all - PowerPoint PPT Presentation

Illustration: =0.4%, =1.2% n =35 per-arm per-stage Do all experimental treatments share a common effect? E.g experimental arm estimate y i = + i where Var( i ) is variance exp arm 5 of y i exp arm 4 Use Cochrans Q statistic to


  1. Illustration: δ =0.4%, σ =1.2% n =35 per-arm per-stage Do all experimental treatments share a common effect? E.g experimental arm estimate y i = µ + ǫ i where Var( ǫ i ) is variance exp arm 5 of y i exp arm 4 Use Cochran’s Q statistic to test null hypothesis. exp arm 3 exp arm 2 Here, p-value for Q is 0.5: No evidence to reject common effect exp arm 1 ( µ ) hypothesis control arm Pooled ‘fixed effect’ estimate for µ Fixed effect estimate ● justified −0.25 0.00 0.25 0.50 0.75 1.00 Compare pooled estimate’s % change in Hba1c Confidence intervals to that of control group and declare class effective if no overlap 1 / 3

  2. Heterogeneity between experimental treatments Perhaps treatments don’t share a common effect? E.g experimental arm estimate y i = µ i + ǫ i where Var( µ i ) is exp arm 5 between arm variation exp arm 4 Between arm variation as a prop n of total variation: I 2 = 50% exp arm 3 exp arm 2 Q statistic p -value=0.09 exp arm 1 I 2 =50% Pooled ‘random-effects’ estimate for control arm µ (= mean of µ i s) arguably justified ● Fixed effect estimate likely to be very similar to fixed effect estimate Random effects estimate ● −0.25 0.00 0.25 0.50 0.75 1.00 Wider confidence interval to % change in Hba1c acknowledge extra uncertainty. Lower power, but arguably right model 2 / 3

  3. Issues surrounding dropped treatments Assume arm 1 & 4 dropped at interim (after 35 patients) Dropped trials have less precise exp arm 5 estimates than kept trials Dropped at stage 1 exp arm 4 Should we exclude dropped arms exp arm 3 when estimating pooled effect? exp arm 2 Exclude : PROS: Remaining arm exp arm 1 results more homogeneous. Likely I 2 (all arms) =62% to opt for a fixed effect estimate. I 2 (kept arms) =17% control arm CONS: Remaining arms potentially ● all arms biased, throwing away information kept arms only ● Include : PROS: Using all available −0.25 0.00 0.25 0.50 0.75 1.00 information. CONS: Confidence % change in Hba1c interval may still be wider due to use of random effects model. 3 / 3

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend